Abstract:
6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof are disclosed. Specifically, the present disclosure discloses novel 6-amino quinazoline or 3-cyano quinoline derivatives presented by general formula (I), or tautomers, enantiomers, diastereomers, racemates or pharmaceutically acceptable salts thereof, or metabolites, metabolic precursors or prodrugs thereof, and their uses as treatment agents especially as protein kinase inhibitors, in which each substitutent group of general formula (I) is as defined in the specification.
Abstract:
6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof are disclosed. Specifically, the present disclosure discloses novel 6-amino quinazoline or 3-cyano quinoline derivatives presented by general formula (I), or tautomers, enantiomers, diastereomers, racemates or pharmaceutically acceptable salts thereof, or metabolites, metabolic precursors or prodrugs thereof, and their uses as treatment agents especially as protein kinase inhibitors, in which each substitutent group of general formula (I) is as defined in the specification.
Abstract:
A phthalazinone ketone derivative as represented by formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, a use thereof as a poly (ADP-ribose) polymerase (PARP) inhibitor, and a cancer treatment method thereof are described.
Abstract:
A phthalazinone ketone derivative as represented by formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, a use thereof as a poly (ADP-ribose) polymerase (PARP) inhibitor, and a cancer treatment method thereof are described.
Abstract:
Provided as represented by formula (I) is a pharmaceutically acceptable salt of (E)-N-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide, a preparation method thereof, and a use thereof as a therapeutic agent, and especially as a protein kinase inhibitor.
Abstract:
A rotor for a dynamoelectric machine includes a rotor core having an outer periphery and at least a first set of magnets positioned within the outer periphery of the rotor core. The first set of magnets includes at least two block magnets and an arc magnet. The block magnets have a substantially parallel magnetization pattern and the arc magnet has a substantially radial magnetization pattern. The arc magnet has a concave surface facing the outer periphery of the rotor core. The first set of magnets defines a pole of the rotor. Rotors with other magnet configurations, and dynamoelectric machines and compressors incorporating such rotors, are also disclosed.
Abstract:
A scintillation-crystal based gamma-ray detector with photon sensors disposed on edge surface(s) of the crystal to take advantage of total internal reflection of scintillation photons within the thin-slab detector substrate to improve spatial resolution of determination of a scintillation event (including depth-of-interaction resolution) while preserving energy resolution and detection efficiency. The proposed structure benefits from the reduced—as compared with related art—total number of readout channels elimination of need in complicated and repetitive cutting and polishing operations to form pixelated crystal arrays used in conventional PET detector modules. Detectors systems utilizing stacks of such detectors, and methods of operation of same.
Abstract:
Methods for producing butadiene by the oxidative dehydrogenation of butene are provided. Methods for producing butadiene from a feed stream including oxygen and butene in a molar ratio of oxygen to butene (O2/C4H8) from about 0.9 to about 1.5 can include introducing the feed stream to a catalyst in the presence of steam. The molar ratio of steam to butene (H2O/C4H8) can be from about 10 to about 20. Methods can further include reacting the butene to generate a product stream therefrom comprising butadiene and water. Methods can further include separating water from the product stream to generate a butadiene stream including greater than about 85 wt-% butadiene.
Abstract:
A magnetic unlocking device and a magnetic unlocking structure of a magnetic encoding key. The magnetic unlocking structure includes a lock core device and a magnetic unlocking device. The lock core device includes a lock core casing, a lock knob which is provided in the internal cavity of the lock core casing, a lock care front end cover and a lock core rear end cover that are located at both ends of the lock core casing. The internal wall of the lock core casing is provided with a monad longitudinal moving groove and a monad horizontal rotating groove. The lock knob is provided with an unlocking hole. The external wall of the lock knob is provided with a monad longitudinal slide-way. The monad longitudinal slide-way and the monad longitudinal moving groove correspond to each other and form a monad moving cavity.
Abstract:
The present invention relates to a composite nano microporous diaphragm for use in lithium ion cells using polyolefin modified with post-crosslinked rubber and manufacturing method thereof. The microporous diaphragm at least comprises a nano microporous diaphragm A layer with a chemical gel content of more than 20%, the microscopic structure thereof is designed to be the rubber material that has been evenly dispersed and has subjected to a post-crosslinking treatment in polyolefin nano microfiber matrix, forming a nano microporous diaphragm of rubber-plastic composite. The nano microporous diaphragm with high strength, thermal cutoff, high temperature resistance, as well as good liquid absorption and swelling and compression elasticity can be applied to lithium ion power cells with high safety and long cycling life.